Sickle-cell thalassemia, unspecified, with crisis
ICD-10 D57.41 is a billable code used to indicate a diagnosis of sickle-cell thalassemia, unspecified, with crisis.
Sickle-cell thalassemia is a genetic blood disorder characterized by the presence of both sickle cell disease and thalassemia, leading to a complex form of hemolytic anemia. Patients with this condition experience episodes of pain known as 'crises' due to the sickling of red blood cells, which can obstruct blood flow and lead to ischemia in various organs. The severity of symptoms can vary widely depending on the specific genetic mutations involved and the proportion of sickle hemoglobin (HbS) and abnormal thalassemia hemoglobin present. Individuals may present with symptoms such as fatigue, pallor, jaundice, and episodes of severe pain. The management of sickle-cell thalassemia often requires a multidisciplinary approach, including pain management, hydration, and sometimes blood transfusions or hydroxyurea therapy to reduce the frequency of crises. Genetic counseling is also crucial for affected individuals and their families to understand inheritance patterns and reproductive options.
Detailed clinical notes on hemoglobin levels, crisis management, and treatment plans.
Management of pain crises, blood transfusions, and monitoring for complications.
Ensure accurate documentation of both sickle cell and thalassemia components.
Genetic testing results and family history documentation.
Counseling patients on inheritance patterns and reproductive options.
Documentation of genetic mutations and their implications for treatment.
Used during acute management of severe anemia or crisis.
Document the reason for transfusion and patient response.
Hematology specialists should ensure accurate coding of transfusion episodes.
Sickle-cell thalassemia is a combination of sickle cell disease and thalassemia, leading to a unique clinical presentation that requires specific management strategies.
